MCID: VSL003
MIFTS: 40

Visual Agnosia

Categories: Eye diseases, Mental diseases

Aliases & Classifications for Visual Agnosia

MalaCards integrated aliases for Visual Agnosia:

Name: Visual Agnosia 12 15
Primary Visual Agnosia 45 74

Classifications:



External Ids:

Disease Ontology 12 DOID:0060155
MeSH 45 C531604
UMLS 74 C2930796

Summaries for Visual Agnosia

Disease Ontology : 12 An agnosia that is a loss of the ability to visually recognize objects.

MalaCards based summary : Visual Agnosia, also known as primary visual agnosia, is related to alexia and agnosia. An important gene associated with Visual Agnosia is GREM2 (Gremlin 2, DAN Family BMP Antagonist), and among its related pathways/superpathways are Wnt / Hedgehog / Notch and Alzheimers Disease Pathway. The drugs Flurbiprofen and Dexmedetomidine have been mentioned in the context of this disorder. Affiliated tissues include brain, cortex and temporal lobe.

Wikipedia : 77 Visual agnosia is an impairment in recognition of visually presented objects. It is not due to a deficit... more...

Related Diseases for Visual Agnosia

Diseases related to Visual Agnosia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 57)
# Related Disease Score Top Affiliating Genes
1 alexia 30.7 KANTR PSEN1
2 agnosia 12.2
3 kluver-bucy syndrome 11.4
4 spastic paraplegia 14 11.1
5 alzheimer disease 4 10.4 PSEN1 PSEN2
6 early-onset, autosomal dominant alzheimer disease 10.3 PSEN1 PSEN2
7 prosopagnosia 10.3
8 mesenteric vascular occlusion 10.3 F7 MB
9 olfactory groove meningioma 10.2 F7 SYP
10 accommodative esotropia 10.2 GREM2 KANTR
11 auditory agnosia 10.2 GREM2 KANTR
12 orbital cancer 10.2 MB SYP
13 rhabdoid cancer 10.2 MB SYP
14 angiomyoma 10.2 MB SYP
15 substernal goiter 10.2 F7 KANTR
16 thymus lipoma 10.2 MB SYP
17 myxosarcoma 10.2 MB SYP
18 apperceptive agnosia 10.2 PSEN1 TOR3A
19 immune system organ benign neoplasm 10.2 MB SYP
20 alzheimer disease 10.2
21 mixed cell type cancer 10.1 MB SYP
22 posterior myocardial infarction 10.1 KANTR MB
23 internuclear ophthalmoplegia 10.1 KANTR PSEN1
24 subendocardial myocardial infarction 10.1 KANTR MB
25 thyroid crisis 10.1 KANTR MB
26 postencephalitic parkinson disease 10.1 KANTR SYP
27 alzheimer disease 2 10.1 PSEN1 PSEN2
28 agraphia 10.1 KANTR PSEN1
29 cardiovascular organ benign neoplasm 10.1 KANTR MB
30 abducens nerve disease 10.1 KANTR SYP
31 functional colonic disease 10.1 KANTR SYP
32 benign perivascular tumor 10.1 KANTR MB
33 radiation cystitis 10.1 F7 KANTR
34 autism 10.1
35 aphasia 10.1
36 punctate epithelial keratoconjunctivitis 10.1 KANTR PSEN2
37 transient global amnesia 10.1 KANTR PSEN1
38 medullomyoblastoma 10.1 MB SYP
39 familial isolated dilated cardiomyopathy 10.1 PSEN1 PSEN2
40 cerebellopontine angle tumor 10.0 KANTR SYP
41 intraocular retinoblastoma 10.0 GREM2 KANTR SYP
42 nervous system disease 10.0 KANTR PSEN1 SYP
43 anterior cranial fossa meningioma 10.0 F7 KANTR SYP
44 colonic pseudo-obstruction 9.9 KANTR SYP
45 rheumatoid arthritis 9.9
46 yemenite deaf-blind hypopigmentation syndrome 9.9
47 arthritis 9.9
48 brain injury 9.9
49 apraxia 9.9
50 amnestic disorder 9.9

Graphical network of the top 20 diseases related to Visual Agnosia:



Diseases related to Visual Agnosia

Symptoms & Phenotypes for Visual Agnosia

Drugs & Therapeutics for Visual Agnosia

Drugs for Visual Agnosia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 109)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Flurbiprofen Approved, Investigational Phase 4 5104-49-4 3394
2
Dexmedetomidine Approved, Vet_approved Phase 4,Not Applicable 113775-47-6 5311068 68602
3
Dezocine Approved, Investigational Phase 4 53648-55-8 3033053 40841
4
Ketamine Approved, Vet_approved Phase 4 6740-88-1 3821
5
Nalbuphine Approved Phase 4 20594-83-6 5311304 5360630
6
Bupivacaine Approved, Investigational Phase 4,Not Applicable 38396-39-3, 2180-92-9 2474
7
Morphine Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 57-27-2 5288826
8
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Not Applicable 50-02-2 5743
9
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4,Not Applicable 1177-87-3
10
Ibuprofen Approved Phase 4,Not Applicable 15687-27-1 3672
11
Acetaminophen Approved Phase 4,Phase 2,Phase 3,Not Applicable 103-90-2 1983
12
Levobupivacaine Approved, Investigational Phase 4,Not Applicable 27262-47-1 92253
13
Lidocaine Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 137-58-6 3676
14
Sufentanil Approved, Investigational Phase 4,Not Applicable 56030-54-7 41693
15
Ropivacaine Approved Phase 4,Phase 3,Not Applicable 84057-95-4 175805 71273
16
Naloxone Approved, Vet_approved Phase 4 465-65-6 5284596
17
Oxycodone Approved, Illicit, Investigational Phase 4 76-42-6 5284603
18
Gabapentin Approved, Investigational Phase 4 60142-96-3 3446
19
Clonidine Approved Phase 4 4205-90-7 2803
20
Tramadol Approved, Investigational Phase 4,Phase 3 27203-92-5 33741
21
Remifentanil Approved Phase 4,Phase 3,Not Applicable 132875-61-7 60815
22
Ketoprofen Approved, Vet_approved Phase 4 22071-15-4 3825
23
Nefopam Approved, Investigational Phase 4 13669-70-0
24
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 3 2078-54-8 4943
25 Analgesics, Opioid Phase 4,Phase 2,Phase 3,Not Applicable
26 Analgesics Phase 4,Phase 2,Phase 3,Not Applicable
27 Adrenergic alpha-Agonists Phase 4,Not Applicable
28 Adrenergic Agents Phase 4,Not Applicable
29 Cyclooxygenase Inhibitors Phase 4,Not Applicable
30 Adrenergic Agonists Phase 4,Not Applicable
31 Central Nervous System Depressants Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
32 Analgesics, Non-Narcotic Phase 4,Phase 2,Phase 3,Not Applicable
33 Neurotransmitter Agents Phase 4,Not Applicable
34 Anti-Inflammatory Agents Phase 4,Not Applicable
35 Adrenergic alpha-2 Receptor Agonists Phase 4,Not Applicable
36 Hypnotics and Sedatives Phase 4,Phase 3,Not Applicable
37 Narcotics Phase 4,Phase 2,Phase 3,Not Applicable
38 Anti-Inflammatory Agents, Non-Steroidal Phase 4,Not Applicable
39 Peripheral Nervous System Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
40 Antirheumatic Agents Phase 4,Not Applicable
41 Excitatory Amino Acid Antagonists Phase 4,Not Applicable
42 Anesthetics Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
43 Anesthetics, Dissociative Phase 4
44 Excitatory Amino Acids Phase 4,Not Applicable
45 Anesthetics, General Phase 4,Phase 3,Not Applicable
46 Anesthetics, Intravenous Phase 4,Phase 3,Not Applicable
47 Adjuvants, Anesthesia Phase 4,Phase 3,Not Applicable
48 Anesthetics, Local Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
49 Antipyretics Phase 4,Phase 2,Phase 3,Not Applicable
50 BB 1101 Phase 4,Not Applicable

Interventional clinical trials:

(show top 50) (show all 73)
# Name Status NCT ID Phase Drugs
1 Effect of Dexmedetomidine for Postoperative Intravenous Patient Controlled Analgesia Unknown status NCT03014713 Phase 4 Dezocine;Flubiprofen;Dexmedetomidine
2 Ketamine and Postoperative Analgesia in Children Unknown status NCT00200564 Phase 4 ketamine
3 Intrathecal Morphine Analgesia vs. Continuous Epidural Analgesia vs. Systemic Analgesia in Colorectal Surgery. Completed NCT03007121 Phase 4 Morphine intrathecal;Bupivacaine + Sufentanil epidural;Morphine intravenous
4 Effects of Catheter Location on Postoperative Analgesia for Continuous Adductor Canal and Popliteal-Sciatic Nerve Blocks Completed NCT02523235 Phase 4 ropivacaine 0.2%
5 The Combination Effect of Dexmedetomidine and Morphine in Postoperative Patient-Controlled Analgesia Completed NCT00800826 Phase 4 dexmedetomidine
6 Early Postoperative Administration of Oxycodone +/- Naloxone and Duration of Epidural Analgesia Completed NCT02516059 Phase 4 oxycodone/naloxone;Oxycodone;Placebo
7 Multimodal Analgesic Treatment Versus Traditional Morphine Analgesia After Cardiac Surgery Completed NCT01966172 Phase 4 Ibuprofen;Gabapentin;Morphine;Paracetamol
8 Postoperative Pain and SIRS After Preoperative Analgesia With Clonidine or Levobupivacaine Completed NCT00860899 Phase 4 clonidine, levobupivacaine
9 Continuous Infusion of Dexamethasone Plus Tramadol Adjunct to Morphine PCA After Abdominal Hysterectomy Completed NCT00564603 Phase 4 Dexamethasone Sodium Phosphate Injection
10 Intravenous and Intraperitoneal Lignocaine for Perioperative Analgesia in Laparoscopic Colon Resections Recruiting NCT03105193 Phase 4 IV Saline bolus and infusion;IP Saline bolus and infusion;IV lignocaine bolus and infusion;IP Lignocaine bolus and infusion
11 Dexmedetomidine Supplemented Analgesia and 2-Year Survival After Cancer Surgery Recruiting NCT03012971 Phase 4 Dexmedetomidine supplemented morphine analgesia;Morphine analgesia
12 Dexmedetomidine Supplemented Intravenous Analgesia in Elderly After Orthopedic Surgery Recruiting NCT03629262 Phase 4 Dexmedetomidine;Placebo
13 Dexmedetomidine Supplemented Analgesia and Incidence of Postoperative Delirium Recruiting NCT03012984 Phase 4 Dexmedetomidine supplemented morphine analgesia;Morphine analgesia
14 Non-opioid Analgesic Combination With Morphine for Postoperative Analgesia. Terminated NCT01882530 Phase 4 Paracetamol;Nefopam;Ketoprofen;Morphine
15 A Study Comparing Two Analgesia/Sedation Regimens, Remifentanil/Propofol Versus Sufentanil/Propofol In Mechanically Ventilated Intensive Care Patients Requiring Analgesia And Sedation. Terminated NCT00421720 Phase 4 Sufentanil;Remifentanil
16 A PhaseⅡ/ Ⅲ Seamless Study to Evaluate Efficacy and Safety of Paracetamol Injection as Adjuvant to Morphine-based Postoperative Analgesia Unknown status NCT02811991 Phase 2, Phase 3 Paracetamol injection;Normal Saline injection;Morhpine PCA
17 Combination Analgesia for Neonatal Circumcision Completed NCT02990364 Phase 3 Sucrose;Lidocaine;EMLA Topical Product
18 Wound Infusion vs Spinal Morphine for Post-caesarean Analgesia Completed NCT02264821 Phase 3 ropivacaine infiltration;intrathecal morphine;placebo
19 Tramadol Versus Fentanyl for Post-Operative Analgesia in Newborn Infants Completed NCT00713726 Phase 3 FentanyL;Tramadol
20 Continuous Regional Analgesia After Total Knee Arthroplasty Completed NCT00337597 Phase 3
21 Pharmacoeconomic Consequences Of Analgesia in the Intensive Care Unit (ICU) Terminated NCT00436345 Phase 3 Remifentanil;Propofol
22 Development of a New Method for Analgesia Completed NCT00791024 Phase 1, Phase 2 CRC-Pharma 001;lidocaine suspension
23 Impact of Preemptive Intravenous Ibuprofen on Intraoperative Analgesia in Third Molar Teeth Unknown status NCT03170726 Not Applicable arveles;intrafen 800 mg
24 Perfusion Index and Labor Analgesia Unknown status NCT03107559
25 Protective Analgesia in Caesarean Section Using Intravenous Paracetamol Unknown status NCT03060265 Not Applicable Paracetamol;PLACEBO
26 Dexamethasone Added to Levobupivacaine Improves Postoperative Analgesia Unknown status NCT01739270 Not Applicable
27 Effect of N-methyl D-aspartate (NMDA) Receptor Antagonist Dextromethorphan on Opiods Analgesia and Tolerance in Pediatric Intensive Care Unit Patients Unknown status NCT01553435 Not Applicable Dextromethorphan;Placebo
28 Do Epidurals Placed at a Lower Level Improve Labor Analgesia? Unknown status NCT00954317 Not Applicable
29 Depodur vs Fentanyl Infusion for Post-C/S Analgesia Unknown status NCT00762554 Not Applicable Depodur;Depodur;Fentanyl
30 Low Level Laser (LED) Use to Increase Dental Implant Stability and Post Operative Analgesia Unknown status NCT01097499 Not Applicable
31 Effect of Thoracic Epidural Analgesia for Thoracotomy on the Occurrence of AF Unknown status NCT01718717 Not Applicable
32 Dietary Supplement for the Prevention of Cognitive Decline in a Very Elderly Population. Unknown status NCT01817101 Not Applicable
33 Perception and Multisensory Integration in Neurological Patients Using fMRI Unknown status NCT01469858 Not Applicable
34 Orientation Agnosia: Clinical and Anatomical Study Completed NCT01304576 Not Applicable
35 Newborn Cortical Response to Pain and Non Pharmacological Analgesia Completed NCT03389789 Not Applicable
36 Comparison of Patient-Controlled Analgesia With Different Background Infusion Completed NCT03221491 Not Applicable
37 Epidural Morphine for Postoperative Analgesia After Total Knee Arthroplasty Completed NCT03203967 Not Applicable Intravenous morphine analgesia
38 Individualized Analgesia on Respiratory Adverse Events After Adenotonsillectomy Completed NCT02990910 Not Applicable personalized opioid analgesia
39 A Randomised Controlled Trial Comparing Single Shot Adductor Canal Block With Local Infiltration Analgesia for Postoperative Analgesia After Total Knee Arthroplasty Completed NCT02104934 Not Applicable
40 μ-opioid Receptor Polymorphism and Opioid Analgesia Completed NCT02099877 Fentanyl
41 The Effect of Oxytocin on Placebo Analgesia: an Experimental Study in Healthy Volunteers Completed NCT01886014 Not Applicable Oxytocin
42 Labour Analgesia and Movement in Babies Completed NCT01280084
43 The Randomised Epidural Analgesia in Term Delivering Women Trial (TREAT) Completed NCT01261689 Not Applicable Ropivacaine/ Sufentanil according to local hospital protocol
44 Effect of Timing on Efficacy of Morphine Analgesia After 2-chloroprocaine Anesthesia Completed NCT00487084 Not Applicable Morphine-CP-saline (MCS);saline-2CP-morphine (SCM);saline-lidocaine-morphine (SLM)
45 Combined Implementation of Dural Puncture Epidural and Programmed Intermittent Epidural Bolus for Labor Analgesia Completed NCT03366935 Not Applicable
46 Individualized Timing of Analgesia and Effectiveness of Labor Analgesia Completed NCT02920489 Not Applicable Individualized epidural analgesia;Routine epidural analgesia
47 Epidural Analgesia in Intensive Care Unit (APD-REA: Analgesie PeriDurale en REAnimation) Completed NCT01437358
48 Effects of Thoracic Epidural Analgesia and Surgery on Lower Urinary Tract Function: A Randomized, Controlled Study Completed NCT01220362 Not Applicable Bupivacain 0.125%;Bupivacain 0.125%/Fentanyl 2mcg/ml
49 Surgical Stress Index as a Tool for Monitoring Analgesia and/or Sedation in Critically Ill Patients Completed NCT00789412
50 Telemedically Supported Analgesia in the Emergency Medical Service Completed NCT01644032 Not Applicable

Search NIH Clinical Center for Visual Agnosia

Cochrane evidence based reviews: primary visual agnosia

Genetic Tests for Visual Agnosia

Anatomical Context for Visual Agnosia

MalaCards organs/tissues related to Visual Agnosia:

42
Brain, Cortex, Temporal Lobe, Colon, Eye, Thyroid, Thymus

Publications for Visual Agnosia

Articles related to Visual Agnosia:

(show top 50) (show all 118)
# Title Authors Year
1
Real-world size coding of solid objects, but not 2-D or 3-D images, in visual agnosia patients with bilateral ventral lesions. ( 30987739 )
2019
2
The neuropsychological rehabilitation of visual agnosia and Balint's syndrome. ( 29366371 )
2018
3
The contribution of facial dynamics to subtle expression recognition in typical viewers and developmental visual agnosia. ( 29723598 )
2018
4
Visual agnosia and focal brain injury. ( 28843416 )
2017
5
Visual agnosia. ( 26358494 )
2016
6
Pearls & Oy-sters: Visual agnosia: An overlooked cortical sign. ( 27821572 )
2016
7
Making memories: the development of long-term visual knowledge in children with visual agnosia. ( 24319599 )
2013
8
Configural Gestalts remain nothing more than the sum of their parts in visual agnosia. ( 25165506 )
2013
9
Impaired integration of emotional faces and affective body context in a rare case of developmental visual agnosia. ( 21482423 )
2012
10
Visual agnosia and posterior cerebral artery infarcts: an anatomical-clinical study. ( 22276198 )
2012
11
The right place at the right time: priming facial expressions with emotional face components in developmental visual agnosia. ( 22349446 )
2012
12
Eye movements during object recognition in visual agnosia. ( 22627025 )
2012
13
Selective impairment of living things and musical instruments on a verbal 'Semantic Knowledge Questionnaire' in a case of apperceptive visual agnosia. ( 22771855 )
2012
14
Perception of biological motion in visual agnosia. ( 22973210 )
2012
15
Visual agnosia. ( 23144207 )
2012
16
Development of a vocabulary of object shapes in a child with a very-early-acquired visual agnosia: a unique case. ( 20680887 )
2011
17
Psychic blindness or visual agnosia: early descriptions of a nervous disorder. ( 21253940 )
2011
18
Modeling eye movements in visual agnosia with a saliency map approach: bottom-up guidance or top-down strategy? ( 21316191 )
2011
19
Separate processing of texture and form in the ventral stream: evidence from FMRI and visual agnosia. ( 19478035 )
2010
20
The neuropsychological and neuroradiological correlates of slowly progressive visual agnosia. ( 19184324 )
2009
21
Fixation and saliency during search of natural scenes: the case of visual agnosia. ( 19428433 )
2009
22
Visual agnosia for line drawings and silhouettes without apparent impairment of real-object recognition: a case report. ( 19996516 )
2009
23
Associative visual agnosia: a case study. ( 18413915 )
2008
24
Chapter 21 Visual agnosia. ( 18631704 )
2008
25
To know what it is for, but not how it is: semantic dissociations in a case of visual agnosia. ( 18704832 )
2008
26
Implicit integration in a case of integrative visual agnosia. ( 17339044 )
2007
27
Impairments in part-whole representations of objects in two cases of integrative visual agnosia. ( 18066732 )
2007
28
Visual agnosia and prosopagnosia secondary to melanoma metastases: case report. ( 29213375 )
2007
29
[Apperceptive form visual agnosia caused by anti-TNFalpha therapy to rheumatoid arthritis]. ( 17511276 )
2007
30
No double-dissociation between optic ataxia and visual agnosia: multiple sub-streams for multiple visuo-manual integrations. ( 16753188 )
2006
31
A two-stage account of computing and binding occluded and visible contours: Evidence from visual agnosia and effects of lorazepam. ( 21049331 )
2006
32
Behavioral change and its neural correlates in visual agnosia after expertise training. ( 15829077 )
2005
33
The role of sensory-motor information in object recognition: evidence from category-specific visual agnosia. ( 15896389 )
2005
34
Visuomotor performance in a patient with visual agnosia due to an early lesion. ( 15130585 )
2004
35
Electrophysiological correlates of associative visual agnosia lesioned in the ventral pathway. ( 15178214 )
2004
36
2D but not 3D: pictorial-depth deficits in a case of visual agnosia. ( 15505981 )
2004
37
Visual agnosia. ( 14565906 )
2003
38
Category-specific visual agnosia: lesion to semantic memory versus extra-lesional variables in a case study and a connectionist model. ( 14642293 )
2003
39
A Case Study of Visual Agnosia without Perceptual Processing or Structural Descriptions Impairment. ( 20957586 )
2003
40
Implicit face perception in a patient with visual agnosia? Evidence from behavioural and eye-tracking analyses. ( 12591027 )
2003
41
What does visual agnosia tell us about perceptual organization and its relationship to object perception? ( 12669745 )
2003
42
Radical "visual capture" observed in a patient with severe visual agnosia. ( 12719638 )
2003
43
Visual agnosia in a child with non-lesional occipito-temporal CSWS. ( 12767457 )
2003
44
Visual agnosia. ( 12916489 )
2003
45
Visual agnosia and prosopagnosia in childhood: a prospective case study. ( 12610772 )
2002
46
The role of premorbid expertise on object identification in a patient with category-specific visual agnosia. ( 20957546 )
2002
47
Animals and artifacts may not be treated equally: differentiating strong and weak forms of category-specific visual agnosia. ( 11237370 )
2001
48
Visual agnosia and Klüver-Bucy syndrome in marmosets (Callithrix jacchus) following ablation of inferotemporal cortex, with additional mnemonic effects of immunotoxic lesions of cholinergic projections to medial temporal areas. ( 11292457 )
2001
49
Early onset epileptic auditory and visual agnosia with spontaneous recovery associated with Tourette's syndrome. ( 11561053 )
2001
50
Visual agnosia after treatment of a posterior fossa ependymoma in a 16-month-old girl. ( 11575616 )
2001

Variations for Visual Agnosia

Expression for Visual Agnosia

Search GEO for disease gene expression data for Visual Agnosia.

Pathways for Visual Agnosia

Pathways related to Visual Agnosia according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.69 CYLD PSEN1 PSEN2
2 10.97 PSEN1 PSEN2
3 10.59 PSEN1 PSEN2
4 10.32 PSEN1 PSEN2
5 9.32 PSEN1 PSEN2

GO Terms for Visual Agnosia

Biological processes related to Visual Agnosia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 response to hypoxia GO:0001666 9.61 F7 MB PSEN2
2 membrane protein ectodomain proteolysis GO:0006509 9.4 PSEN1 PSEN2
3 regulation of protein binding GO:0043393 9.37 CYLD PSEN1
4 amyloid-beta metabolic process GO:0050435 9.32 PSEN1 PSEN2
5 Notch receptor processing GO:0007220 9.26 PSEN1 PSEN2
6 amyloid precursor protein catabolic process GO:0042987 9.16 PSEN1 PSEN2
7 Notch receptor processing, ligand-dependent GO:0035333 8.96 PSEN1 PSEN2
8 protein processing GO:0016485 8.8 F7 PSEN1 PSEN2

Molecular functions related to Visual Agnosia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 peptidase activity GO:0008233 9.56 CYLD F7 PSEN1 PSEN2
2 aspartic-type endopeptidase activity GO:0004190 9.16 PSEN1 PSEN2
3 endopeptidase activity GO:0004175 9.13 F7 PSEN1 PSEN2
4 aspartic endopeptidase activity, intramembrane cleaving GO:0042500 8.62 PSEN1 PSEN2

Sources for Visual Agnosia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....